214 related articles for article (PubMed ID: 10477400)
21. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
[TBL] [Abstract][Full Text] [Related]
22. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
23. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
Zhang D; Li J; Jiang Z; Yu B; Tang X
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
[TBL] [Abstract][Full Text] [Related]
24. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
27. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
Maier B; Lehnert M; Laurer HL; Mautes AE; Steudel WI; Marzi I
Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
[TBL] [Abstract][Full Text] [Related]
28. [TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis].
Geppert A; Losy J
Neurol Neurochir Pol; 1999; 33(4):807-14. PubMed ID: 10612095
[TBL] [Abstract][Full Text] [Related]
29. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
30. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
[TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid IL-6, HSP72, and TNF-alpha in exercising humans.
Steensberg A; Dalsgaard MK; Secher NH; Pedersen BK
Brain Behav Immun; 2006 Nov; 20(6):585-9. PubMed ID: 16647242
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of tumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis.
Baraczka K; Pozsonyi T; Szüts I; Ormos G; Nékám K
Acta Microbiol Immunol Hung; 2003; 50(4):339-48. PubMed ID: 14750436
[TBL] [Abstract][Full Text] [Related]
34. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis.
Tokushige K; Yamaguchi N; Ikeda I; Hashimoto E; Yamauchi K; Hayashi N
Am J Gastroenterol; 2000 Aug; 95(8):2040-6. PubMed ID: 10950055
[TBL] [Abstract][Full Text] [Related]
35. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
36. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects.
Gao IK; Scholz P; Boehme MW; Norden C; Lemmel EM
Rheumatol Int; 2002 Jun; 22(2):45-51. PubMed ID: 12070674
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.
Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P
Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554
[TBL] [Abstract][Full Text] [Related]
38. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.
Dellalibera-Joviliano R; Dos Reis ML; Cunha Fde Q; Donadi EA
J Rheumatol; 2003 Mar; 30(3):485-92. PubMed ID: 12610806
[TBL] [Abstract][Full Text] [Related]
39. Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis.
Thangarajh M; Gomes A; Masterman T; Hillert J; Hjelmström P
J Neuroimmunol; 2004 Jul; 152(1-2):183-90. PubMed ID: 15223251
[TBL] [Abstract][Full Text] [Related]
40. TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
Desplat-Jégo S; Feuillet L; Creidy R; Malikova I; Rance R; Khrestchatisky M; Hahm K; Burkly LC; Pelletier J; Boucraut J
J Leukoc Biol; 2009 Jan; 85(1):132-5. PubMed ID: 18945822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]